Evaluating the Impact of a New Complement to Physiotherapy Intervention for Positional Torticollis in Infants
Launched by MCGILL UNIVERSITY HEALTH CENTRE/RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE · Apr 9, 2009
Trial Information
Current as of June 24, 2025
Terminated
Keywords
ClinConnect Summary
160 children of less than 6 months of age will be recruited for the study and divided in 2 groups. Children of both groups will receive the same physiotherapy evaluation and exercises but parents will receive information handouts with one of two different types of illustrations and written instructions for home exercises.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged newborn to 6 months at initial visit in physiotherapy,
- • A diagnosis of PT made by a physician,
- • At least 37 weeks of gestational age at delivery
- Exclusion Criteria:
- • Congenital muscular torticollis with fibrosis (confirmed diagnosis): because this is a rare condition that has a different rate of recovery,
- • Presence of craniosynostosis (confirmed diagnosis made by a neurosurgeon),
- • APGAR score of less than 7 at 5 minutes,
- • Prescription of a Tubular Orthosis for Torticollis (TOT) collar or Botox intervention for the torticollis,
- • Confirmed diagnosis of syndrome or neurological condition.
About Mcgill University Health Centre/Research Institute Of The Mcgill University Health Centre
The McGill University Health Centre (MUHC) and the Research Institute of the McGill University Health Centre (RI-MUHC) are leading institutions in clinical research and healthcare innovation. With a commitment to advancing medical knowledge and improving patient outcomes, the MUHC integrates cutting-edge research with high-quality patient care. The RI-MUHC fosters a collaborative environment where multidisciplinary teams engage in transformative research across various fields, including oncology, neurology, and cardiovascular health. By leveraging state-of-the-art facilities and a robust network of clinical expertise, both entities strive to translate scientific discoveries into effective treatments, ultimately enhancing the quality of life for patients locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montreal, Quebec, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials